Row:For the years ended December 31
in thousands, except per share data
	2019 	2018 	2017
Row:Total revenues Cost of revenues 	$ 4,929,103 3,673,202 	$ 4,382,869 $ 3,281,924 	3,890,296
2,896,783
Row:Gross profit 	1,255,901 	1,100,945 	993,513
Row:Selling, administrative and general expenses 	370,548 	333,371 	324,972
Row:Gain on sale of property, plant & equipment and businesses 	23,752 	14,944 	17,827
Row:Other operating expense, net 	(31,647) 	(34,805) 	(47,324)
Row:Operating earnings 	877,458 	747,713 	639,044
Row:Other nonoperating income, net Interest income Interest expense 	9,243 1,155 130,155 	13,000 554 137,977 	13,357
4,437
295,522
Row:Earnings from continuing operations before income taxes Income tax expense (benefit)
Current Deferred 	757,701 58,941 76,257 	623,290 40,516 64,933 	361,316
354
(232,429)
Row:Total income tax expense (benefit) 	135,198 	105,449 	(232,075)
Row:Earnings from continuing operations Earnings (loss) on discontinued operations, net of tax 	622,503 (4,841) 	517,841 (2,036) 	593,391
7,794
Row:Net earnings Other comprehensive income (loss), net of tax
Deferred gain on interest rate derivative Amortization of prior interest rate derivative loss Adjustment for funded status of benefit plans Amortization of actuarial loss and prior service cost for benefit plans 	$ 617,662 0 227 (26,892) 1,142 	$ 515,805 $ 2,496 226 (207) 4,365 	601,185
0
1,862
(14,106)
2,154
Row:Other comprehensive income (loss) 	(25,523) 	6,880 	(10,090)
Row:Comprehensive income 	$ 592,139 	$ 522,685 $ 	591,095
Row:Basic earnings (loss) per share
Continuing operations Discontinued operations Net earnings 	$ 4.71 (0.04) $ 4.67 	$ 3.91 $ (0.01) $ 3.90 $ 	4.48
0.06
4.54
Row:Diluted earnings (loss) per share
Continuing operations Discontinued operations Net earnings 	$ 4.67 (0.04) $ 4.63 	$ 3.87 $ (0.02) $ 3.85 $ 	4.40
0.06
4.46
Row:Weighted-average common shares outstanding
Basic Assuming dilution 	132,300 133,385 	132,393 133,926 	132,513
134,878
Row:The accompanying Notes to Consolidated Financial Statements are an integral part of 	these statements.
		Row:As of December 31
in thousands
		Row:Assets
Cash and cash equivalents 	$ 271,589 	$ 40,037
Row:Restricted cash 	2,917 	4,367
Row:Accounts and notes receivable
Customers, less allowance for doubtful accounts
2019 — $3,125; 2018 — $2,090 	532,012 	512,279
Row:Other 	38,104 	28,499
Row:Inventories 	458,308 	429,330
Row:Other current assets 	76,396 	64,633
Row:Total current assets Investments and long-term receivables 	1,379,326 60,709 	1,079,145
44,615
Row:Property, plant & equipment, net 	4,316,038 	4,237,307
Row:Operating lease right-of-use assets, net Goodwill 	408,189 3,167,061 	0
3,165,396
Row:Other intangible assets, net 	1,091,475 	1,095,378
Row:Other noncurrent assets 	225,995 	210,289
Row:Total assets 	$ 10,648,793 	$ 9,832,130
Row:Liabilities
Current maturities of long-term debt 	25 	23
Row:Short-term debt Trade payables and accruals 	0 265,159 	133,000
216,473
Row:Accrued salaries, wages and management incentives 	97,228 	91,960
Row:Accrued interest Other current liabilities Total current liabilities Long-term debt 	19,167 153,984 535,563 2,784,315 	19,631
141,463
602,550
2,779,357
Row:Deferred income taxes, net 	633,039 	567,283
Row:Deferred management incentive and other compensation 	22,856 	16,604
Row:Pension benefits 	142,363 	119,587
Row:Other postretirement benefits 	35,848 	35,274
Row:Asset retirement obligations 	210,323 	225,726
Row:Deferred revenue 	179,880 	186,397
Row:Operating lease liabilities Other noncurrent liabilities 	388,042 94,707 	0
96,449
Row:Total liabilities 	$ 5,026,936 	$ 4,629,227
Row:Other commitments and contingencies (Note 12)
		Row:Equity
Common stock, $1 par value, Authorized 480,000 shares,
Outstanding 132,371 and 131,762 shares, respectively Capital in excess of par value 	132,371 2,791,353 	131,762
2,798,486
Row:Retained earnings 	2,895,871 	2,444,870
Row:Accumulated other comprehensive loss 	(197,738) 	(172,215)
Row:Total equity 	5,621,857 	5,202,903
Row:For the years ended December 31
in thousands
	2019 	2018 	2017
Row:Operating Activities
Net earnings $ 	617,662 	$ 515,805 $ 	601,185
Row:Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation, depletion, accretion and amortization Noncash operating lease expense 	374,596 35,344 	346,246 0 	305,965
0
Row:Net gain on sale of property, plant & equipment and businesses 	(23,752) 	(14,944) 	(17,827)
Row:Contributions to pension plans Share-based compensation expense 	(8,882) 31,843 	(109,631) 25,215 	(20,023)
26,635
Row:Deferred tax expense (benefit) 	76,011 	64,639 	(235,697)
Row:Cost of debt purchase 	0 	6,922 	140,772
Row:(Increase) decrease in assets excluding the initial effects of business
acquisitions and dispositions
			Row:Accounts and notes receivable 	(29,734) 	63,230 	(81,561)
Row:Inventories 	(28,273) 	(34,976) 	(14,121)
Row:Prepaid expenses 	5,990 	(2,167) 	(28,445)
Row:Other assets 	(61,195) 	(58,489) 	(23,759)
Row:Increase (decrease) in liabilities excluding the initial effects of business
acquisitions and dispositions
			Row:Accrued interest and income taxes Trade payables and other accruals 	(4,644) 21,788 	12,148 40,181 	1,303
9,823
Row:Other noncurrent liabilities Other, net 	(51,150) 28,518 	(26,901) 5,499 	(32,592)
13,020
Row:Net cash provided by operating activities $ 	984,122 	$ 832,777 $ 	644,678
Row:Investing Activities
Purchases of property, plant & equipment Proceeds from sale of property, plant & equipment 	(384,094) 22,661 	(469,088) 22,210 	(459,566)
15,756
Row:Proceeds from sale of businesses Payment for businesses acquired, net of acquired cash Other, net Net cash used for investing activities $ 	1,744 (44,151) (11,997) (415,837) 	11,256 (221,419) (12,850) $ (669,891) 	287,292
(1,109,725)
(3,248)
$ (1,269,491)
Row:Financing Activities
Proceeds from short-term debt Payment of short-term debt 	366,900 (499,900) 	739,900 (606,900) 	5,000
(5,000)
Row:Payment of current maturities and long-term debt Proceeds from issuance of long-term debt Debt issuance and exchange costs Settlements of interest rate derivatives Purchases of common stock 	(23) 0 0 0 (2,602) 	(892,055) 850,000 (45,513) 3,378 (133,983) 	(1,463,308)
2,200,000
(15,291)
0
(60,303)
Row:Dividends paid 	(163,973) 	(148,109) 	(132,335)
Row:Share-based compensation, shares withheld for taxes 	(38,585) 	(31,846) 	(25,323)
Row:Net cash provided by (used for) financing activities $ 	(338,183) 	$ (265,128) $ 	503,440
Row:Net increase (decrease) in cash and cash equivalents and restricted cash 	230,102 	(102,242) 	(121,373)
Row:Cash and cash equivalents and restricted cash at beginning of year 	44,404 	146,646 	268,019
Row:Cash and cash equivalents and restricted cash at end of year $ 	274,506 	$ 44,404 $ 	146,646
Row:The accompanying Notes to Consolidated Financial Statements are an integral part of these 	statements.
		